To our knowledge, there are four small observational real-life retrospective single-center studies [15,16,18,19] and one observational multicenter retrospective study [17] which examined the impact on glycemic profile, maternal and neonatal complications in pregnant women with T1DM using commercially available automated insulin delivery (AID) systems. The gene discussed is INS; the disease is type 1 diabetes mellitus.